We are live on ! Find out more
HEPA

Hepion Pharmaceuticals
HEPA

Delisted

HEPA was delisted on the 12th of May, 2025.

Back to rankings

3 hedge funds and large institutions have $3.38M invested in Hepion Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3 → 3 (0)

50% less capital invested

Capital invested by funds: $6.79M → $3.38M (-$3.41M)

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Nomura Holdings
Nomura Holdings
Japan
-$17K
2
EWA
Exencial Wealth Advisors
Oklahoma
-$10K
3
UBS Group
UBS Group
Switzerland
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
1
Teachers Advisors
New York
$1.6M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$989K – – –
Morgan Stanley
3
Morgan Stanley
New York
$250K – – –
PFS
4
Prospera Financial Services
Texas
$207K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$124K – – –
Bank of Montreal
6
Bank of Montreal
Ontario, Canada
$32K – – –
Barclays
7
Barclays
United Kingdom
$28K – – –
Bank of New York Mellon
8
Bank of New York Mellon
New York
$27K – – –
Cambridge Investment Research Advisors
9
Cambridge Investment Research Advisors
Iowa
$21K – – –
Northern Trust
10
Northern Trust
Illinois
$18K – – –
BFA
11
BlackRock Fund Advisors
California
$16K – – –
LWM
12
LBA Wealth Management
Florida
$15K – – –
VKH
13
Virtu KCG Holdings
New York
$14K – – –
BIT
14
BlackRock Institutional Trust
California
$12K – – –
BA
15
BlackRock Advisors
Delaware
$6K – – –
Creative Planning
16
Creative Planning
Kansas
$6K – – –
TCIM
17
TIAA CREF Investment Management
New York
$5.72K – – –
Wells Fargo
18
Wells Fargo
California
$5K – – –
NFG
19
Next Financial Group
Texas
$2K – – –
Bank of America
20
Bank of America
North Carolina
$1K – – –
Deutsche Bank
21
Deutsche Bank
Germany
$1K – – –
JFA
22
JNBA Financial Advisors
Minnesota
$1K – – –
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$1K – – –
S
24
SignatureFD
Georgia
$1K – – –
VIA
25
Vantage Investment Advisors
Pennsylvania
$1K – – –
1
2

HEPA Hedge Fund Activity: Q3 2016 in Review

3 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Hepion Pharmaceuticals (HEPA) for Q3 2016, worth a combined $3.38M — down 50% from $6.79M a quarter earlier.

Fund positioning in HEPA was balanced in Q3 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Nomura Holdings, cutting an estimated $17K.

  • 3 institutional investors held Hepion Pharmaceuticals (HEPA) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $3.38M of Hepion Pharmaceuticals stock for Q3 2016, down 50% quarter-over-quarter.
  • 0 funds opened new Hepion Pharmaceuticals positions in Q3 2016 and 0 closed out.
  • The largest Hepion Pharmaceuticals seller in Q3 2016 was Nomura Holdings, an estimated $17K sold.

Based on aggregated 13F filings for Q3 2016.